Screener
Veradermics MANE Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Veradermics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 5:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001827635-26-000019
| (in thousands, except share and per share amounts) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest income | 2,481 | 482 |
| Other income | 149 | 33 |
| Total other income, net | 2,630 | 515 |
| Loss before income taxes | (27,232) | (12,400) |
| Income tax benefit | — | — |
| Net loss | $(27,232) | $(12,400) |
| Net loss attributable to common stock | $(30,011) | $(14,582) |
| Net loss per share of common stock, basic and diluted | $(1.32) | $(19.79) |
Item 1. Condensed Consolidated Financial Statements (
FAQ
- What is Veradermics's pre-tax income?
- Veradermics (MANE) reported pre-tax income of -$27.23M in Q1 2026.
- How has Veradermics's pre-tax income changed year-over-year?
- Veradermics's pre-tax income decreased by 119.6% year-over-year, from -$12.4M to -$27.23M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Veradermics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude